5th annual World Orphan Drug Congress Europe

Europe’s largest commercially-focused event for the rare disease industry - World Orphan Drug CongressThe 5th annual World Orphan Drug Congress Europe is the region’s largest event that delivers solutions to the industry’s most pressing issues around Clinical Development, Market Access, Pricing and Reimbursement, Patient Advocacy and Corporate Development.

The congress is a one-stop shop for the industry’s complete value chain. A keynote conference, an exhibition, a networking forum and patient advocacy forum. An event where pharma, biotech, patient bodies, regulators and payers come together to learn, network and partner.

The congress has a proven track record of delivering:

  • Large Pharma
  • MidCap and SME Biotech
  • Academia and Research Institutes
  • Payers and Reimbursors
  • National Regulators
  • National Rare Disease Alliances
  • Patient Federations
  • Patient Organisations and patients
  • Plus leading service and solution providers